Building biofuels’ field of dreams at the Energy Biosciences Institute

We recently had lunch with Chris Somerville, director of the Energy Biosciences Institute (EBI) at the University of California at Berkeley. The EBI was funded with a $500 million investment from BP, and looks at a wide variety of issues at the intersection of biology and energy. While we discussed ...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Low-energy nuclear reactions are not a hoax (mostly) but also not a viable energy technology

Research Brief | December 14, 2021

Every so often, clients ask us about low‑energy nuclear reactions (LENRs). This type of nuclear reaction certainly sounds intriguing. If someone could get it to work, it would be a shortcut to cheap fusion energy that could be deployed within a decade. If that sounds too good to be true, that's ... Not part of subscription

Huh? CO₂-to-cellulose? Rubi Laboratories raises USD 4.5 million to develop CO₂-derived viscose

News Commentary | February 25, 2022

At the intersection of synthetic biology, CO2 utilization, and cellulosic fibers is Rubi Laboratories. Rubi is aiming to produce carbon‑negative viscose using its enzyme‑based CO2‑to‑cellulose technology. Unlike other CO2‑derived fiber developers like LanzaTech, Newlight Technologies, and Fairbrics ... Not part of subscription

De-extinction? Colossal raises USD 75 M on the climate change wave to drive applied molecular research

News Commentary | March 15, 2022

Colossal will advance its research into de‑extinction to "slow climate change." Its initial target is the woolly mammoth. In reality, Colossal will not de‑extinct a woolly mammoth, but produce a different organism altogether — the Arctic elephant — using mammoth and Asian elephant DNA. This approach... Not part of subscription